Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

NCT06034535 is registered in ClinicalTrials.gov with Hong Kong Children's Hospital as lead sponsor.

NCT NCT06034535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06034535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Lead sponsor
Hong Kong Children's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
September 1, 2023
Completion date
September 30, 2026
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic organs; disorder